EQT is looking to offload its stake in HMI Medical, a Singapore-based hospital and healthcare services group, at a valuation of approximately $600 million, according to The Wall Street Journal. The process is at an early stage.

HMI Medical operates private hospitals and specialist clinics across Southeast Asia, serving a region where demographic tailwinds — an ageing population, a growing middle class with rising healthcare spend, and constrained public-sector capacity — have made healthcare assets consistently attractive to institutional capital. EQT, the Stockholm-headquartered private equity and infrastructure firm, has been an active acquirer and disposer of healthcare assets globally, and Southeast Asian healthcare has been one of the more liquid sub-sectors for PE exits over the past several years.

At $600 million, the implied price puts HMI in a bracket that would interest a range of potential acquirers: regional strategic buyers, sovereign wealth vehicles with a healthcare mandate, and larger PE sponsors looking to build or extend platform positions in ASEAN healthcare. Singapore's status as a regional medical hub — drawing patients from across Southeast Asia and beyond — adds a pricing premium to assets with exposure there that would not apply to comparable operators in less medically sophisticated markets.

The early-stage characterisation of the process matters. At this point, no binding bids have been reported, no shortlist has been disclosed, and the $600 million figure represents an asking price or valuation expectation rather than a concluded transaction value. Deal processes of this type in Asia routinely attract early interest that does not translate into binding offers, and headline valuations often shift materially between launch and close. Readers should treat the $600 million figure as a directional signal, not a locked price.

For EQT, the timing of a potential disposal reflects the standard calculus of PE lifecycle management: funds have finite lives, and exits need to be executed within windows that allow capital to be returned to LPs. Whether the firm is working to a specific fund deadline or is simply capitalising on continued appetite for quality healthcare assets in the region is not disclosed.

The broader context for this transaction sits within a sustained wave of PE-backed healthcare consolidation across Southeast Asia. Operators in Malaysia, Indonesia, and Singapore have attracted significant sponsor capital over the past decade, with IHH Healthcare, Parkway, and a range of smaller platforms changing hands or attracting strategic minority stakes. A successful EQT exit from HMI at or near $600 million would validate continued premium pricing for the sector, even as higher-for-longer interest rates have compressed exit multiples in other industries.

What happens next depends heavily on process design — whether EQT runs a structured auction, a targeted bilateral process, or something in between — and on how potential buyers assess HMI's earnings trajectory, debt load, and competitive positioning relative to both public-market healthcare comparables and recent private transactions. None of those details are in the public domain at this stage.

For now, EQT has a willing seller, an early-stage process, and a $600 million target. The market will price the rest.